Ads
related to: pet scan results for lymphoma survival rate- Case Studies
Review real case studies
with real patients.
- Sign Up for Updates
Sign up to receive the latest data,
case studies, and resources.
- Contact Us
Contact our representatives
for product and reimbursement info.
- Find an Imaging Site
Locate the nearest imaging site
or contact customer service.
- Case Studies
discoverpanel.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Negative interim PET scan results probably result in a large increase in the overall survival compared to those with a positive interim PET scan result. [ 62 ] Current research evaluated whether Nivolumab can be used for the treatment of a Hodgkin's lymphoma.
A 2020 review of research on the use of PET for Hodgkin lymphoma found evidence that negative findings in interim PET scans are linked to higher overall survival and progression-free survival; however, the certainty of the available evidence was moderate for survival, and very low for progression-free survival. [11]
The evidence is very uncertain about the effect of negative (= good prognosis) or positive (= bad prognosis) interim PET scan results for patients with a Hodgkin's lymphoma on the progression-free survival. Negative interim PET scan results may result in an increase in progression-free survival compared if the adjusted result was measured.
A FDG PET scan is commonly advised following the completion of ABVD to assess response to the therapy. Interim PET (following 2 cycles) may be useful in aiding prognostication, but does not yet guide changes in therapy except within clinical trial protocols.
>30% increase in 18F-FDG SUL peak, with >0.8 SUL units increase in tumor SUV peak from the baseline scan in pattern typical of tumor and not of infection/treatment effect. or Visible increase in the extent of 18F-FDG tumor uptake. or New 18F-FDG avid lesions which are typical of cancer and not related to treatment effect or infection.
Progression-free survival (PFS) is "the length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse". [1] In oncology , PFS usually refers to situations in which a tumor is present, as demonstrated by laboratory testing, radiologic testing, or clinically.
Ads
related to: pet scan results for lymphoma survival ratediscoverpanel.com has been visited by 10K+ users in the past month